1. Home
  2. OPBK vs HURA Comparison

OPBK vs HURA Comparison

Compare OPBK & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPBK
  • HURA
  • Stock Information
  • Founded
  • OPBK 2005
  • HURA 2009
  • Country
  • OPBK United States
  • HURA United States
  • Employees
  • OPBK N/A
  • HURA N/A
  • Industry
  • OPBK Major Banks
  • HURA
  • Sector
  • OPBK Finance
  • HURA
  • Exchange
  • OPBK Nasdaq
  • HURA Nasdaq
  • Market Cap
  • OPBK 235.5M
  • HURA 193.8M
  • IPO Year
  • OPBK 2018
  • HURA N/A
  • Fundamental
  • Price
  • OPBK $16.51
  • HURA $4.70
  • Analyst Decision
  • OPBK Hold
  • HURA
  • Analyst Count
  • OPBK 1
  • HURA 0
  • Target Price
  • OPBK $13.00
  • HURA N/A
  • AVG Volume (30 Days)
  • OPBK 38.4K
  • HURA 85.4K
  • Earning Date
  • OPBK 10-24-2024
  • HURA 11-26-2024
  • Dividend Yield
  • OPBK 2.91%
  • HURA N/A
  • EPS Growth
  • OPBK N/A
  • HURA N/A
  • EPS
  • OPBK 1.39
  • HURA N/A
  • Revenue
  • OPBK $78,759,000.00
  • HURA N/A
  • Revenue This Year
  • OPBK N/A
  • HURA N/A
  • Revenue Next Year
  • OPBK $12.64
  • HURA N/A
  • P/E Ratio
  • OPBK $11.87
  • HURA N/A
  • Revenue Growth
  • OPBK N/A
  • HURA N/A
  • 52 Week Low
  • OPBK $8.47
  • HURA $2.84
  • 52 Week High
  • OPBK $18.29
  • HURA $17.36
  • Technical
  • Relative Strength Index (RSI)
  • OPBK 73.39
  • HURA N/A
  • Support Level
  • OPBK $14.47
  • HURA N/A
  • Resistance Level
  • OPBK $18.29
  • HURA N/A
  • Average True Range (ATR)
  • OPBK 0.68
  • HURA 0.00
  • MACD
  • OPBK 0.12
  • HURA 0.00
  • Stochastic Oscillator
  • OPBK 53.52
  • HURA 0.00

About OPBK OP Bancorp

OP Bancorp is engaged in the general commercial banking business in Los Angeles, Orange, and Santa Clara Counties, California, Carrollton, Texas, and Las Vegas, Nevada. The Bank is focused on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a particular emphasis on Korean and other ethnic minority communities. It operates with eleven full branches.

About HURA TuHURA Biosciences Inc. Common Stock

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

Share on Social Networks: